OrbiMed Capital GP III LLC, 10% Owner at PIERIS PHARMACEUTICALS, INC. (PIRS), sold 147,635 shares at $5.70 ($842K) on 2017-12-18, disclosed to the SEC on 2017-12-20.
Open-market sale of $842k PIRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.70 | 1,392 | $8K | 0.9% |
| 2 | $5.70 | 146,243 | $834K | 99.1% |
| Total | $5.70 avg | 147,635 | $842K | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| ROKA | SELL | 2017-10-05 | $273K | — | Filing → |